FIRM FIXED PRICENO SET ASIDE USED.

JUBILANT DRAXIMAGE RADIOPHARMACIES, INC. - MERTIATIDE MAG3, COMPOUNDED R057A0 I-131 CAPSULES.

PIID: HT001422P0007
Signed Date: Oct 16, 2025Effective Date: Oct 22, 2021End Date: Closed on Oct 22, 2025
Award $
$252K
Vendor
JUBILANT DRAXIMAGE RADIOPHARMACIES, INC.
NAICS
339112
Signed Date
Oct 16, 2025

Key Details

Dollars Obligated
$251,570.05
Base & All Options
Awarding Agency
Department of Defense
Awarding Sub-Agency
Defense Health Agency
Product Service Code
6515 - MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES
Extent Competed
NOT COMPETED UNDER SAP
Number of Offers
1
Place of Performance
BETHESDA, MD, 208895600, CD-MD-08

Description

MERTIATIDE MAG3, COMPOUNDED R057A0 I-131 CAPSULES.

Context & Analysis

On Oct 16, 2025, Department of Defense obligated $251,570.05 to JUBILANT DRAXIMAGE RADIOPHARMACIES, INC. for mertiatide mag3, compounded r057a0 i-131 capsules.. The award is classified under NAICS 339112 — SURGICAL AND MEDICAL INSTRUMENT MANUFACTURING and issued as a firm fixed price contract. Competition extent: not competed under sap with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in BETHESDA, MD. This award is one of several similar procurements from Department of Defense under NAICS 339112 — related awards are listed below.

Contractor Information

UEI: EQ4VSLH8RC33
CAGE Code: 7XH67
Location: ORLANDO, FL
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related